Literature DB >> 15545018

Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability.

Tomas Palomo1, R M Kostrzewa, R J Beninger, T Archer.   

Abstract

Factors that confer predisposition and vulnerability for alcoholism and other substance abuse disorders may be described usefully within the gene-environment interplay framework. Thus, it is postulated that heritability provides a major contribution not only to alcohol but also to other substances of abuse. Studies of evoked potential amplitude reduction have provided a highly suitable and testable method for the assessment of both environmentally-determined and heritable characteristics pertaining to substance use and dependence. The different personal attributes that may co-exist with parental influence or exist in a shared, monozygotic relationship contribute to the final expression of addiction. In this connection, it appears that personality disorders are highly prevalent co-morbid conditions among addicted individuals, and, this co-morbidity is likely to be accounted for by multiple complex etiological relationships, not least in adolescent individuals. Co-morbidity associated with deficient executive functioning may be observed too in alcohol-related aggressiveness and crimes of violence. The successful intervention into alcohol dependence and craving brought about by baclofen in both human and animal studies elucidates glutamatergic mechanisms in alcoholism whereas the role of the dopamine transporter, in conjunction with both the noradrenergic and serotonergic transporters, are implicated in cocaine dependence and craving. The role of the cannabinoids in ontogeny through an influence upon the expression of key genes for the development of neurotransmitter systems must be considered. Finally, the particular form of behaviour/characteristic outcome due to childhood circumstance may lie with biological, gene-based determinants, for example individual characteristics of monoamine oxidase (MAO) activity levels, thereby rendering simple predictive measures both redundant and misguiding.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15545018     DOI: 10.1007/bf03033309

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  318 in total

1.  Individual differences in mood reactions to d-amphetamine: a test of three personality factors.

Authors:  P J Corr; V Kumari
Journal:  J Psychopharmacol       Date:  2000       Impact factor: 4.153

2.  Adolescent antisocial behavior and substance use: longitudinal analyses.

Authors:  Sigrun Adalbjarnardottir; Fjolvar Darri Rafnsson
Journal:  Addict Behav       Date:  2002 Mar-Apr       Impact factor: 3.913

3.  Personality, drug of choice, and comorbid psychopathology among substance abusers.

Authors:  Kevin P Conway; Joel D Swendsen; Bruce J Rounsaville; Kathleen Ries Merikangas
Journal:  Drug Alcohol Depend       Date:  2002-02-01       Impact factor: 4.492

Review 4.  The role of the dopamine transporter in cocaine abuse.

Authors:  Sari Izenwasser
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 5.  Prevalence of personality disorders among clients in treatment for addiction.

Authors:  L Nadeau; M Landry; S Racine
Journal:  Can J Psychiatry       Date:  1999-08       Impact factor: 4.356

6.  Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine.

Authors:  C A Heidbreder; A C Thompson; T S Shippenberg
Journal:  J Pharmacol Exp Ther       Date:  1996-08       Impact factor: 4.030

7.  Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans.

Authors:  M Mas; M Farré; R de la Torre; P N Roset; J Ortuño; J Segura; J Camí
Journal:  J Pharmacol Exp Ther       Date:  1999-07       Impact factor: 4.030

8.  Sex differences in the sources of genetic liability to alcohol abuse and dependence in a population-based sample of U.S. twins.

Authors:  C A Prescott; S H Aggen; K S Kendler
Journal:  Alcohol Clin Exp Res       Date:  1999-07       Impact factor: 3.455

9.  Adolescents with attention deficit hyperactivity disorder: mother-adolescent interactions, family beliefs and conflicts, and maternal psychopathology.

Authors:  R A Barkley; A D Anastopoulos; D C Guevremont; K E Fletcher
Journal:  J Abnorm Child Psychol       Date:  1992-06

10.  ESBRA-Nordmann 1998 Award Lecture: Visual P3 as a potential vulnerability marker of alcoholism: evidence from the Amsterdam study of children of alcoholics. European Society for Biomedical Research on Alcoholism.

Authors:  O Van Der Stelt
Journal:  Alcohol Alcohol       Date:  1999 May-Jun       Impact factor: 2.826

View more
  6 in total

Review 1.  Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism?

Authors:  Robert M Roth; Mary F Brunette; Alan I Green
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

Review 2.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 3.  Gene-environment interplay in neurogenesis and neurodegeneration.

Authors:  Tomás Palomo; Trevor Archer; Richard J Beninger; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

4.  Affective status in relation to impulsive, motor and motivational symptoms: personality, development and physical exercise.

Authors:  Tomas Palomo; Richard J Beninger; Richard M Kostrzewa; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

5.  Pairing mild stress with increased serotonin-1B receptor expression in the nucleus accumbens increases susceptibility to amphetamine.

Authors:  Susan M Ferguson; Nolan A Sandygren; John F Neumaier
Journal:  Eur J Neurosci       Date:  2009-10-08       Impact factor: 3.386

Review 6.  Genetic variation and shared biological susceptibility underlying comorbidity in neuropsychiatry.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2007-07       Impact factor: 3.911

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.